Alyssa Kritz

Biomedical engineering

Hometown: Chicago, Illinois, United States

Graduation date: Spring 2022

Health icon, disabled. A red heart with a cardiac rhythm running through it.

FURI | Spring 2022

Chemotherapeutic Drug-Conjugated Microbead Technology for Selective Binding with Methylated and Unmethylated Small DNA in the Application of Disease Detection and Biomanufacturing

In a previous study, it was discovered that aminoglycoside-derived cationic polymer microbeads (also called Amikabeads) have significant binding affinity toward negatively charged plasmid DNA due to coulombic interactions. The purpose of this study is to develop a small library of modified Amikabeads with a variety of DNA-intercalating chemotherapeutic drug molecules to modulate the ability of DNA binding. Further investigation on how these ligand-modified beads interact with small methylated and unmethylated DNA fragments (which mimics circulating tumor DNA or ctDNA) would help to develop a new technology for cancer detection and aid in improving biomanufacturing methods in the future.

Mentor:

View the poster
QR code for the current page

It’s hip to be square.

Students presenting projects at the symposium are encouraged to download this personal QR code and include it within your poster. This allows symposium attendees to explore more about your project and about you in the future. 

Right click the image to save it to your computer.

Additional projects from this student

Studying the interactions between chemotherapeutic drug-conjugated microbeads and small DNA fragments will help develop new biotechnology for cancer detection.

Mentor:

  • FURI
  • Fall 2021

FURI Totals

TotalStudents

0

FacultyMentors

0

OnlineSymposia

0

FocusAreas

0

FURIProjects

0

MOREProjects

0

KEENProjects

0

GCSPProjects

0